BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11110700)

  • 21. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.
    Falanga A; Marchetti M; Vignoli A; Balducci D; Russo L; Guerini V; Barbui T
    Exp Hematol; 2007 May; 35(5):702-11. PubMed ID: 17577920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Royat Study Group.
    Boneu B; Leger P; Arnaud C
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):129-35. PubMed ID: 9622210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia.
    Falanga A; Ofosu FA; Cortelazzo S; Delaini F; Marziali S; Barbui T
    Semin Thromb Hemost; 1994; 20(4):324-7. PubMed ID: 7899862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia.
    Musolino C; Allegra A; Saija A; Alonci A; Russo S; Spatari G; Penna G; Gerace D; Cristani M; David A; Saitta S; Gangemi S
    Clin Biochem; 2012 Nov; 45(16-17):1439-43. PubMed ID: 22850610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis.
    López-Aguirre Y; Páramo JA
    Thromb Res; 1999 Apr; 94(2):95-101. PubMed ID: 10230894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis.
    Hergesell O; Andrassy K; Nawroth P
    Thromb Haemost; 1996 Jun; 75(6):892-8. PubMed ID: 8822582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera.
    Allegra A; Alonci A; Bellomo G; Campo S; Cannavò A; Penna G; Russo S; Centorrino R; Gerace D; Petrungaro A; Musolino C
    Leuk Lymphoma; 2011 Jan; 52(1):101-7. PubMed ID: 21133718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders.
    Marchetti M; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):148-59. PubMed ID: 19176988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.
    Wada H; Mori Y; Kaneko T; Wakita Y; Nakase T; Minamikawa K; Ohiwa M; Tamaki S; Tanigawa M; Kageyama S
    Am J Hematol; 1993 Oct; 44(2):112-6. PubMed ID: 8266915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
    Kamiunten A; Shide K; Kameda T; Sekine M; Kubuki Y; Ito M; Toyama T; Kawano N; Marutsuka K; Maeda K; Takeuchi M; Kawano H; Sato S; Ishizaki J; Akizuki K; Tahira Y; Shimoda H; Hidaka T; Yamashita K; Matsuoka H; Shimoda K
    Int J Hematol; 2018 Jun; 107(6):681-688. PubMed ID: 29488167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Thromb Res; 1998 Apr; 90(2):51-6. PubMed ID: 9684757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.